pharmacy benefit managers

Share:

We posted a number of times about questionable practices Eli Lilly used to market its atypical anti-psychotic drug Zyprexa (olanzapine).

A post from 2007, with links backward, is here, and our most recent post is here.

The company remains entangled in litigation over its marketing of this drug.

In posts such as here and here, it's become apparent that "Evidence Based Medicine" (EBM), while perhaps reasonable in theory, is probably unreasonable in practice with the ethics of healthcare in 2008.

Another day, another settlement (of charges that a big health care organization deceived patients and physicians)...

Here is the story summarized in the Wall Street Journal:

Pharmacy-benefits manager Express Scripts Inc. agreed to pay $9.5 million to settle allegations that it asked doctors to switch drugs primarily so it could get bigger rebates from pharmaceutical companies.